We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.65 | 0.555 | 0.745 | - | 242,076 | 08:31:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Food Preparations, Nec | 802k | -586k | -0.0002 | -32.50 | 15.25M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/12/2019 11:05 | Some interesting data, very complicated though. Is this fruitflow #1? Appears that the dosing could increase to achieve more aggregation reduction. | gunsofmarscapone | |
05/12/2019 17:03 | All this research on the Health benefits of fruitflow by the Chinese has not cost Provexis anything but it is clear to me that all this research implies the Chinese company By-Health is now ready to produce and sell Fruitflow products in China and around the world based on the collaboration deal between Provexis and DSM and the Chinese company By-Health. And I would not be surprised based on the "No conflict of interest factor" that the Chinese government or other companies supported by the Chinese government are in talks with DSM and Provexis and By-Health to also produce and sell other Fruitflow products in China for their athletes etc. and as like our National Health Service a Chinese Health Service that provides natural health products like Fruitflow. IMHO | wheelds | |
05/12/2019 16:23 | THIS CLEARLY HIGHLIGHTS JUST HOW MUCH RESEARCH HAS GONE INTO THE HEALTH BENEFITS OF FRUITFLOW BY THE CHINESE AUTHORITIES/GOVERNME "This work was financially supported by the China Academy of Chinese Medical Sciences (ZZ11-044)." "Financial support and sponsorship" "This work was financially supported by the China Academy of Chinese Medical Sciences (ZZ11-044)." "Conflicts of interest" "There are no conflicts of interest." | wheelds | |
27/11/2019 08:53 | This is what we want | winner31 | |
01/11/2019 14:37 | That reads like a handle turning exercise using a standard template which they've fed a few numbers into winner31. Apart from it stating the bleeding obvious about a fund raise being required ( which we know anyway ) I wouldn't take any notice of what they say about us ( or any other company for that matter ) | bareknee | |
31/10/2019 22:20 | Broadly positive , | winner31 | |
28/10/2019 15:08 | Too little too late Wheelds or better late than never? Flyfitflow was meant to be rolled out years ago - it got rolled out and then pulled. Sadly this is available to only first class passengers which is very much the tip of the iceberg. It is actually the economy passengers who have far less legroom who need it the most! I can only hope that it catches on and gets sold in airport shops. | redprince | |
26/10/2019 13:04 | AT LAST FLYFITFLOW IS NOW ON SALE. | wheelds | |
26/10/2019 05:27 | Could this be the way into probiotics. Du pont was the worlds largest chemical company , is this the global being hinted at in finals | winner31 | |
21/10/2019 19:04 | Twodegrees could be an isa transfer , but I don’t think the share price would rise if it is , someone building a stake I would guess or existing holder increasing , time will tell . | winner31 | |
21/10/2019 18:33 | winner 31, see another 7+million trade showing up. could this just be transfers or is someone accumulating | twodegrees | |
19/10/2019 14:49 | Notable News Buzz: Provexis Plc, (LON: PXS) October 18, 2019 No Comments LON: PXSProvexis Plc On Thursday the Provexis Plc, LON: PXS), the Trending-Graph. Every buying and selling session display one-of-a-kind measures and patterns about PXS stock.Now we observed the Many factors that seen on close of the Previous session. Toward the day’s end, it’s only a stock’s show that issues. Summary Of The Provexis Plc In Stock Exchange LON: The PXS share price closed at 0.38 with the change of 0.03 during the period of last trading session. Trading volume can help an investor to identify the momentum in a stock and confirm a trend. If trading volume raised, prices generally move in a similar direction. That is, if security is proceeding higher in an uptrend, the volume of the protection should also increase and vice versa. The Company’s current volume remained at 3424534.00. It will be even better to share yesterday’s volume of the Company, i.e., 1237316.00. Market Capitalization of Provexis Plc : Market Capitalization is the accurate measure of a company’s value. There’s a common misconception that a company’s each-share stock price holds as much importance as its market capitalization when it comes to picking stocks to buy. This fallacy occurs especially often in the case of new investors. The market capitalization of the Company recorded at PXS. Buy/Sell/Hold Analysis of PXS: Buy Signals: An event or condition that alerts a person to place a purchase order for an investment. Buy signals can be either observed by analyzing chart patterns or calculated by trading systems. Hold Signals: An analyst’s recommendation to neither purchase nor sell a security. A company or organization with a hold recommendation mostly is required to perform with the market or a similar pace as comparable companies. | winner31 | |
18/10/2019 20:22 | winner 31, now that and the other buys of 1000000 plus is a good sign...of what ...who knows...but at least something is happening | twodegrees | |
18/10/2019 16:39 | Twodegrees looks like a big 7500000 buy yesterday just gone through , probably the reason for the rise | winner31 | |
18/10/2019 09:34 | why the sudden spike in the share price. seems to be some steady buying going on and yet no news. | twodegrees | |
03/10/2019 14:14 | winner31 - tomorrow is not likely to reveal anything new - it rarely does if ever in fact.They are trying to tell us as much as By-Health will allow but frankly as we approach 2 years since we were supposed to see product launched, to witness the remuneration and ridiculous share options that we are is unaccepptable. This company has had a succession of events that could have been avoided which when aggregated have left every long term holder materially much worse off. Aimho.Dyor. | redprince | |
03/10/2019 11:12 | RP let’s see if they have anything to add tomorrow ,I am of course not happy with what’s happening , they now need to let some of the promise come home for us pi’s although I believe they are powerless in the arrangement with DSM but that was of their own making , if approvals have passed SAMR they need to let the market know so the share price can achieve a realistic level ,all the secrecy is not helping their case . | winner31 | |
03/10/2019 09:50 | winner31 - it might be nice but let's be hinest.He earns £120k a year for managing the administration of patents and maintaining the comms with By-Health. He has just been awarded 50m options at 0.3p with no detail given on the performance required to achieve them. That is frankly unacceptable.These guys are issuing paper like confetti. | redprince | |
02/10/2019 14:36 | you girls still buying this POS ? After all I have told ya's too | buywell3 | |
12/9/2019 15:15 | Nice to see IF buying 5m with his own money! I wouldn’t think the placing shares would be set below this ,unless IF is an idiot which I don’t think he is ! | winner31 | |
11/9/2019 07:19 | Agreed , if that happens in the next 6 months then ,raising funds will be no problem ! They certainly didn’t want the share price to rise until they got their options ,maybe the reason for lack of news ! | winner31 | |
11/9/2019 07:13 | winner31 - as he clearly does not even understand the purpose of the filter function i would wager you are correct. Next material news should be SAMR approval. | redprince | |
10/9/2019 16:10 | RED PONCE don't make me come and stay here for a while ...you won't like it. | chimers | |
10/9/2019 15:46 | I would say just plain thick ,also on filter | winner31 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions